Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy.

Mercadal S, Ahn KW, Allbee-Johnson M, Ganguly S, Geethakumari PR, Hong S, Malone A, Murthy H, Pawarode A, Sica AR, Solh M, Ustun C, Shadman M, Sauter CS, Hamadani M, Herrera AF, Lee CJ

Open source

DOI: 10.3324/haematol.2024.285613
Published: 2025 Jan 1
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2024.285613,
  title = {Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy.},
  author = {Mercadal S and Ahn KW and Allbee-Johnson M and Ganguly S and Geethakumari PR and Hong S and Malone A and Murthy H and Pawarode A and Sica AR and Solh M and Ustun C and Shadman M and Sauter CS and Hamadani M and Herrera AF and Lee CJ},
  year = {2025},
  journal = {Haematologica},
  doi = {10.3324/haematol.2024.285613},
  url = {https://doi.org/10.3324/haematol.2024.285613}
}

RIS

TY  - JOUR
TI  - Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy.
AU  - Mercadal S
AU  - Ahn KW
AU  - Allbee-Johnson M
AU  - Ganguly S
AU  - Geethakumari PR
AU  - Hong S
AU  - Malone A
AU  - Murthy H
AU  - Pawarode A
AU  - Sica AR
AU  - Solh M
AU  - Ustun C
AU  - Shadman M
AU  - Sauter CS
AU  - Hamadani M
AU  - Herrera AF
AU  - Lee CJ
PY  - 2025
JO  - Haematologica
DO  - 10.3324/haematol.2024.285613
UR  - https://doi.org/10.3324/haematol.2024.285613
ER  -

APA

S, M., KW, A., M, A., S, G., PR, G., S, H., A, M., H, M., A, P., AR, S., M, S., C, U., M, S., CS, S., M, H., AF, H., & CJ, L. (2025). Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy.. Haematologica. https://doi.org/10.3324/haematol.2024.285613

Source records

pubmed · retrieved 2026-09-26T18:04:09.870Z